From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes.

A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s ...

Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Immatics today and set a price target of $17.00. Stranahan covers the Healthcare sector, focusing on stocks such as Novavax ...

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users ...

The Danish drugmaker said the accelerated approval was based on results from its Step Up trial, which showed 20.7% mean ...

March 19 (Reuters) - Novo Nordisk said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its ...

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose.

Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) ...

March 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Bristol Myers Squibb's combination treatment ...

The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage ...